Showing results (131-140 of 191) with videos related to
Sort By:
Pageof 20
JAMA|May 11, 1999
Natural history of progression after PSA elevation following radical prostatectomyC R Pound, A W Partin, M A Eisenberger, et al.The Journal of Urology|April 1, 1989
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasiaJ P Weber, J E Oesterling, C A Peters, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 26, 1998
The prognostic significance of troponin I and troponin TG B Green, D J Li, E S Bessman, et al.The American Journal of Forensic Medicine and Pathology|January 14, 1999
Serum concentrations of cardiac troponin I in sudden death: a pilot studyS J Cina, D J Li, D W Chan, et al.Progress in Clinical and Biological Research|January 1, 1989
The value of prostate-specific antigen in the management of localized prostatic cancerP C Walsh, J E Oesterling, J I Epstein, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 3, 2001
Cardiac troponin T and C-reactive protein as markers of acute cardiac allograft rejectionJ J Chance, J B Segal, G Wallerson, et al.International Journal of Radiation Biology|August 26, 1998
Lack of correlation between ATM protein expression and tumour cell radiosensitivityD W Chan, D P Gately, S Urban, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|August 26, 2000
CK-MB isoforms for early risk stratification of emergency department patientsG B Green, E Dehlinger, T S McGrievey, et al.Cancer Letters|April 27, 2001
Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patientsY Wang, F P Kuhajda, J N Li, et al.The Journal of Urology|July 1, 1993
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerA W Partin, J Yoo, H B Carter, et al.Pageof 20